Výsledky vyhledávání - "Nicholas WS Chew"

Akademický článek

Effectiveness of an Artificial Intelligence-Assisted App for Improving Eating Behaviors: Mixed Methods Evaluation

Autor: Han Shi Jocelyn Chew, Nicholas WS Chew, Shaun Seh Ern Loong, Su Lin Lim, Wai San Wilson Tam, Yip Han Chin, Ariana M Chao, Georgios K Dimitriadish, Yujia Gao, Jimmy Bok Yan So, Asim Shabbir, Kee Yuan Ngiam

Publikováno v: Journal of Medical Internet Research, Vol 26, p e46036 (2024)

BackgroundA plethora of weight management apps are available, but many individuals, especially those living with overweight and obesity, still struggle to achieve adequate weight loss. An emerging area in weight management is the support for one’s

Externí odkaz: https://doaj.org/article/92b25a2b2da24b11aeb95fddedfba648

Zobrazit plný text záznamu

Akademický článek

Continued demographic shifts in hospitalised patients with COVID-19 from migrant workers to a vulnerable and more elderly local population at risk of severe disease

Autor: Jinghao Nicholas Ngiam, Srishti Chhabra, Wilson Goh, Meng Ying Sim, Nicholas WS Chew, Ching-Hui Sia, Gail Brenda Cross, Paul Anantharajah Tambyah

Publikováno v: International Journal of Infectious Diseases, Vol 127, Iss , Pp 77-84 (2023)

Objectives: In the early months of the COVID-19 pandemic in Singapore, the vast majority of infected persons were migrant workers living in dormitories who had few medical comorbidities. In 2021, with the Delta and Omicron waves, this shifted to the

Externí odkaz: https://doaj.org/article/69d7190471b941548ab05a418e737165

Zobrazit plný text záznamu

Akademický článek

The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease

Autor: Cheng Han Ng, Kai En Chan, Yip Han Chin, Rebecca Wenling Zeng, Pei Chen Tsai, Wen Hui Lim, Darren Jun Hao Tan, Chin Meng Khoo, Lay Hoon Goh, Zheng Jye Ling, Anand Kulkarni, Lung-Yi Loey Mak, Daniel Q Huang, Mark Chan, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J. Sanyal, Mark Muthiah

Publikováno v: Clinical and Molecular Hepatology, Vol 28, Iss 3, Pp 565-574 (2022)

Background/Aims Nonalcoholic fatty liver disease (NAFLD) is closely associated with diabetes. The cumulative impact of both diseases synergistically increases risk of adverse events. However, present population analysis is predominantly conducted wit

Externí odkaz: https://doaj.org/article/737e07a73dbf4a638075e146e094357a

Zobrazit plný text záznamu

Akademický článek

Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals

Publikováno v: Clinical and Molecular Hepatology, Vol 28, Iss 3, Pp 483-496 (2022)

Background/Aims Non-alcoholic fatty liver disease (NAFLD) is associated with the development of cardiovascular disease. While existing studies have examined cardiac remodeling in NAFLD, there has been less emphasis on the development of carotid ather

Externí odkaz: https://doaj.org/article/6b6d5630aac840db9fc0557d9bb72d6f

Zobrazit plný text záznamu

Akademický článek

Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis

Publikováno v: Annals of Hepatology, Vol 28, Iss 1, Pp 100762- (2023)

ABSTRACT: Introduction and Objectives: Type 2 Diabetes Mellitus (T2DM) is comorbidity commonly presenting with fatty liver. A recently proposed definition of ''metabolic associated fatty liver disease'' (MAFLD) is thought to replace non-alcoholic fat

Externí odkaz: https://doaj.org/article/0c881f16cfd748c5ac0a0664b7fc766d

Zobrazit plný text záznamu

Akademický článek

The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysis

Publikováno v: EClinicalMedicine, Vol 54, Iss , Pp 101685- (2022)

Summary: Background: There is a growing number of trials examining the effectiveness of pharmacotherapies for obesity, however, little is known about placebo and nocebo effect in these trials. Hence, we sought to examine the effect of placebo in obes

Externí odkaz: https://doaj.org/article/222cbfecf9a94fc1ac2610b7ce7335d8

Zobrazit plný text záznamu

Akademický článek

Prevalence and outcomes of concomitant cardiac amyloidosis and aortic stenosis: A systematic review and meta-analysis

Autor: Jamie Sin-Ying Ho, Qianyi Kor, William KF. Kong, Yoke Ching Lim, Mark Yan-Yee Chan, Nicholas LX. Syn, Jinghao Nicholas Ngiam, Nicholas WS. Chew, Tiong-Cheng Yeo, Ping Chai, Kian-Keong Poh, Raymond CC. Wong, Weiqin Lin, Ching-Hui Sia

Publikováno v: Hellenic Journal of Cardiology, Vol 64, Iss , Pp 67-76 (2022)

Objective: Cardiac amyloidosis (CA) is an increasingly recognised condition in patients with aortic stenosis (AS). However, there is a large variation in the reported prevalence figures, due to differences in populations and diagnostic methods. We ai

Externí odkaz: https://doaj.org/article/a1c9a9974cbe45e0a71cbf63ef56180b

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání